CITI-FM

Excel Diagnostics and Nuclear Oncology Center Announces FDA Authorization of IND for 225Ac-PSMA I&T Targeted Alpha Therapy for Castration Resistant Prostate Cancer

Retrieved on: 
Wednesday, August 4, 2021

Houston, TX, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Excel Diagnostics and Nuclear Oncology Center (EDNOC), a premier Diagnostic Imaging and Radioligand Therapy center in Houston, Texas announces approval of its physicians sponsored Investigational New Drug (IND) application for providing Targeted Alpha Therapy (TAT) with 225Ac-PSMA I&T for metastatic Castration-Resistant Prostate Cancer (mCRPC).

Key Points: 
  • Houston, TX, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Excel Diagnostics and Nuclear Oncology Center (EDNOC), a premier Diagnostic Imaging and Radioligand Therapy center in Houston, Texas announces approval of its physicians sponsored Investigational New Drug (IND) application for providing Targeted Alpha Therapy (TAT) with 225Ac-PSMA I&T for metastatic Castration-Resistant Prostate Cancer (mCRPC).
  • Excel Diagnostics and Nuclear Oncology Center has been a pioneer in bringing new targeted Radioligand Therapies such as Lu-177 DOTATATE, and Lu-177 PSMA to serve our patients in the United States.
  • Highly encouraging results have been reported by using Targeted Alpha Therapy (TAT) Radiopharmaceuticals in conditions such as neuroendocrine, prostate, or hematological malignancies.
  • In April of 2020, Excel passed FDA inspection of one of its investigational drugs with no deficiencies or citations.

Renowned Author Malcolm Gladwell Confirmed to Keynote at DPHARM 2021 from the Conference Forum

Retrieved on: 
Wednesday, August 4, 2021

NEW YORK, Aug. 4, 2021 /PRNewswire-PRWeb/ -- The Conference Forum has announced that best-selling author Malcolm Gladwell is confirmed to keynote at the 11th annual DPHARM: Disruptive Innovations to Advance Clinical Research conference on September 28, 2021 at the Westin Boston Seaport District in Boston, MA.

Key Points: 
  • NEW YORK, Aug. 4, 2021 /PRNewswire-PRWeb/ -- The Conference Forum has announced that best-selling author Malcolm Gladwell is confirmed to keynote at the 11th annual DPHARM: Disruptive Innovations to Advance Clinical Research conference on September 28, 2021 at the Westin Boston Seaport District in Boston, MA.
  • Malcolm Gladwell, author of several best-selling books including The Tipping Point, Blink, Outliers and most recently, The Bomber Mafia, will address the DPHARM audience of R&D professionals, many of whom worked on COVID vaccines and therapies and kept R&D going throughout the pandemic.
  • Malcolm Gladwell is perhaps best known for his provocative ideas that have taken the business world by storm.
  • Lisa Coleman, PhD, New York University, who will unpack the relationship between unconscious bias and its impact on innovation.

DPHARM Launches its 11th Annual Clinical Trials Innovation Conference with Patient Co-Chairs and More from the Conference Forum

Retrieved on: 
Tuesday, August 3, 2021

"We are delighted to feature patient representation in leadership roles co-chairing sessions at DPHARM," said Valerie Bowling, Executive Director, DPHARM.

Key Points: 
  • "We are delighted to feature patient representation in leadership roles co-chairing sessions at DPHARM," said Valerie Bowling, Executive Director, DPHARM.
  • Best-selling author Malcolm Gladwell, who will present his views on innovation in a post-COVID world.
  • Lisa Coleman, PhD, New York University, who will unpack the relationship between unconscious bias and its impact on innovation.
  • "DPHARM has long been a critical gathering place for those seeking to advance innovative solutions in medicine development," said Craig Lipset, Advisor and Founder, Clinical Innovation Partners and DPHARM Advisor.

Citi Second Quarter 2021 Fixed Income Investor Review

Retrieved on: 
Wednesday, July 14, 2021

Mark Mason, Chief Financial Officer, and Michael Verdeschi, Treasurer, will conduct the Citigroup second quarter 2021 Fixed Income Investor Review at 1:00 PM (ET) on Friday, July 30, 2021.

Key Points: 

Citigroup Reports Second Quarter 2021 Results

Retrieved on: 
Wednesday, July 14, 2021

Both the earnings release and Citigroups Second Quarter 2021 Quarterly Financial Data Supplement are available on Citigroups website at http://www.citigroup.com/citi/investor .

Key Points: 

Citi to Create North American Internal Audit Hub in Mississauga

Retrieved on: 
Tuesday, May 25, 2021

TORONTO, May 25, 2021 /CNW Telbec/ -Citi (NYSE: C) has designated its Mississauga, Ontario,site as a strategic hub for its North American Internal Audit organization and plans to add over 60 positions this year.

Key Points: 
  • TORONTO, May 25, 2021 /CNW Telbec/ -Citi (NYSE: C) has designated its Mississauga, Ontario,site as a strategic hub for its North American Internal Audit organization and plans to add over 60 positions this year.
  • Mississauga was chosendue toboth the quality and depth of the financial services talent pool in the Greater Toronto Area (GTA), and Canada's relative cost advantages compared to other major North American markets.
  • Citi's other strategic locations for Internal Audit in North America are New York, Tampa, and Dallas.
  • "I am thrilled that Citi has chosen its Mississauga site as a strategic hub for its North American Internal Audit organization.

Citi Announces Retirement of Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster

Retrieved on: 
Thursday, March 11, 2021

DUBAI, UAE, March 11, 2021 /PRNewswire/ -- After 37 years with Citi,Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster, will retire from Citi.

Key Points: 
  • DUBAI, UAE, March 11, 2021 /PRNewswire/ -- After 37 years with Citi,Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster, will retire from Citi.
  • Atiq has made immense contributions to Citi, including playing a pivotal role in the evolution of Citi's leading emerging markets franchise.
  • Atiq joined Citi graduate trainee programme in Pakistan in 1984, moving to London in 1993 to take up a role in investment banking.
  • In 2019, Atiq assumed leadership of the newly created EMEA EM Cluster, covering activities in 29 of 55 presence countries in the region.

Citi Announces Retirement of Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster

Retrieved on: 
Thursday, March 11, 2021

DUBAI, UAE, March 11, 2021 /PRNewswire/ -- After 37 years with Citi,Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster, will retire from Citi.

Key Points: 
  • DUBAI, UAE, March 11, 2021 /PRNewswire/ -- After 37 years with Citi,Atiq Rehman, Head of EMEA Emerging Markets (EM) Cluster, will retire from Citi.
  • Atiq has made immense contributions to Citi, including playing a pivotal role in the evolution of Citi's leading emerging markets franchise.
  • Atiq joined Citi graduate trainee programme in Pakistan in 1984, moving to London in 1993 to take up a role in investment banking.
  • In 2019, Atiq assumed leadership of the newly created EMEA EM Cluster, covering activities in 29 of 55 presence countries in the region.

Citi Fourth Quarter 2020 Fixed Income Investor Review

Retrieved on: 
Tuesday, January 19, 2021

Mark Mason, Chief Financial Officer, and Michael Verdeschi, Treasurer, will conduct the Citigroup fourth quarter 2020 Fixed Income Investor Review at 11:00 AM (ET) on Friday, January 29, 2021.

Key Points: 

Citigroup Reports Fourth Quarter 2020 Results

Retrieved on: 
Friday, January 15, 2021

Both the earnings release and Citigroups Fourth Quarter 2020 Quarterly Financial Data Supplement are available on Citigroups website at http://www.citigroup.com/citi/investor .

Key Points: